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Abstract
Background. An important aim of integrated care for frail elderly is to generate more cost-
effective health care. However, empirical research on the cost-effectiveness of integrated care for 
community-dwelling frail elderly is limited. 
Objective. This study reports on the cost-effectiveness of the Walcheren Integrated Care Model 
(WICM) after 12 months from a societal perspective.
Methods. The design of this study was quasi-experimental. In total, 184 frail elderly patients from 
3 GP practices that implemented the WICM were compared with 193 frail elderly patients of 5 GP 
practices that provided care as usual. Effects were determined by health-related quality of life (EQ-
5D questionnaire). Costs were assessed based on questionnaires, GP files, time registrations and 
reports from multidisciplinary meetings. Average costs and effects were compared using t-tests. 
The incremental cost-effectiveness ratio (ICER) was calculated, and bootstrap methods were used 
to determine its reliability.
Results. Neither the WICM nor care as usual resulted in a change in health-related quality of life. The 
average total costs of the WICM were higher than care as usual (17 089 euros versus 15 189 euros). 
The incremental effects were 0.00, whereas the incremental costs were 1970 euros, indicating an 
ICER of 412 450 euros.
Conclusions. The WICM is not cost-effective, and the costs per quality-adjusted life year are high. 
The costs of the integrated care intervention do not outweigh the limited effects on health-related 
quality of life after 12  months. More analyses of the cost-effectiveness of integrated care for 
community-dwelling frail elderly are recommended as well as consideration of the specific costs 
and effects.
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Introduction 
Due to population ageing, primary care systems throughout the 
world are encountering great challenges urging innovation in the 
organization of elderly care. Elderly individuals will gradually expe-
rience complex age-related problems in the physical, psychological, 
cognitive and social domains of daily functioning. This condition is 
known as frailty and is found to increase the risk of negative health 
and social outcomes. Frailty is related to poor quality of life and 
becoming more care dependent, with an increased likelihood of hos-
pitalization and institutionalization (1). While budget cuts reduce 
health and social care expenditures, there is, thus, a strong need for 
providing high-quality care in order to maintain elderly’s quality of 
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life. It is frequently questioned whether the current approach to care 
delivery provides good value for money, given its fragmentation and 
its lack of responsiveness to the needs of frail elderly (2). Therefore, 
it is essential to consider alternatives.
Integrated care has been increasingly advocated as a means to 
deliver value for money. Integrated care is defined as ‘a well-planned 
and well-organised set of services and care processes, targeted at multi-
dimensional needs/problems of an individual client, or a category of 
persons with similar needs/problems’ (3). The two main features of inte-
grated care are client centredness and continuity. First, integrated care is 
demand-oriented, addressing client’s needs by professionals from differ-
ent disciplines and sectors (2). Second, integrated care aims to promote 
continuity: the set of services is delivered coherently, seamlessly and in 
accordance with clients’ changing needs over time (3). Common ele-
ments of integrated care models proven to be effective for community-
dwelling frail elderly are a single entry point, geriatric assessments, case 
management, multidisciplinary teams (4), multidisciplinary protocols 
and discussions, web-based patient files and a network structure (5).
Even though integrated care largely aims at cost-effectiveness, 
research comparing the associated costs and effects of interventions 
is scarce, limiting conclusions on the cost-effectiveness of integrated 
care interventions (6). Thus far, studies on cost-effectiveness have 
also shown mixed results. Some interventions for community-dwell-
ing frail elderly have shown to be cost-effective compared with care 
as usual (6–9), whereas other studies have shown that integrated 
care is not cost-effective (10,11). The wide variation in the interven-
tions, costs and effects considered in these studies, limits the possibil-
ity to draw conclusions regarding what promotes cost-effectiveness 
in integrated care for community-dwelling frail elderly.
This study adds knowledge by exploring the cost-effectiveness of 
a specific integrated care intervention: the Walcheren Integrated Care 
Model (WICM). Our study is relevant for two reasons. In contrast to 
earlier studies that used a narrow health care perspective (6,7,9), we 
adopted a societal perspective, which is strongly recommended given its 
policy relevance at the macro level (12). Second, our intervention com-
prises all integrated care elements that have been identified as effective 
in prior research rather than a selection of elements. Therefore, we pro-
vide valuable insights regarding the cost-effectiveness of a comprehen-
sive integrated care model for community-dwelling frail elderly. This 
study aimed to answer the following research question: Is the WICM 
cost-effective from a societal perspective after 12 months?
Methods
Design
The design of this study was quasi-experimental and included before 
and after measurements with a control group providing care as usual 
[for a more detailed description of the methods, see ref. (13)]. The 
cost-effectiveness analysis was conducted from a societal perspective 
and thus considered all costs related to the intervention, irrespective 
of who pays for these expenses (12).
Intervention
In the WICM, the GP functions as care coordinator and as a partner 
in prevention. The GP practice is a single entry point for the elderly, 
their informal caregivers and health professionals. GPs detect frailty 
in their patient population using the Groningen Frailty Indicator, a 
validated 15-item instrument that measures decreases in physical, 
cognitive, social and psychological functioning. Elderly patients with 
a score of 4 or higher are visited by a nurse practitioner who assesses 
their functional, cognitive, mental and psychological functioning 
using EASYcare, an evidence-based instrument used to assess care 
needs. A  multidisciplinary treatment plan is then formulated in 
consultation with the elderly and their informal caregiver(s). Case 
management is provided by the nurse practitioner. Multidisciplinary 
meetings are attended by the GP, the nurse practitioner and other 
professionals, depending on the care required by the frail elderly. 
The entire process is supported by web-based patient files and mul-
tidisciplinary protocols. The WICM requires task reassignment and 
delegation between nurses and doctors, and among GPs, nursing 
home doctors and geriatricians. Consultations occur among primary, 
secondary and tertiary care providers. At the organizational level, a 
steering group serves as an umbrella organization under which the 
WICM is developed and disseminated. The steering group, which 
consists of representatives from all involved organizations, forms 
a Joint Governing Board that provides the necessary provider net-
work. All patient representatives support the project, and the health 
insurer CZ provides financial support for the project.
Compared with the WICM, care as usual in the Netherlands is 
fragmented and reactive. In the Dutch health care systems, patients 
need a referral from their GP to obtain care from the primary, sec-
ondary and tertiary echelons. GPs thus play the role of gatekeepers. 
Care as usual is fragmented, as professionals merely communicate 
bilaterally through referral letters and sporadic telephone calls. 
Moreover, care as usual is reactive; patients solely receive care for 
specific (health) problems on their own initiative. The GPs in the 
control group were unable to implement elements of the integrated 
model during the study period because they did not receive financial 
support from the health insurer to implement the integrated care 
activities of the WICM. Accordingly, participants in the control 
group were not systematically screened for frailty, their care needs 
were not assessed, multidisciplinary treatment plan were not for-
mulated and case management was not provided. The GPs in the 
control group had a monodisciplinary focus; they did not organize 
multidisciplinary meetings or implement multidisciplinary proto-
cols and web-based files. Furthermore, the GPs in the control group 
could not treat the frail elderly patients differently, as these GPs were 
not given information on who participated in the study. Therefore, 
the probability of bias was minimized.
Participants
The study population consisted of the entire elderly patient population 
of the GPs in both the experimental and control groups (see Fig. 1). 
At baseline, 254 frail elderly from three GP practices were included in 
the experimental group, and 249 frail elderly from six GP practices in 
the control group. The frail elderly were asked whether they received 
informal care, including care from non-professionals and unpaid care 
provided by partners, family, close friends or neighbours. At base-
line, 144 frail elderly in the experimental group reported receiving 
informal care compared with 118 frail elderly in the control group. 
After 12 months, the final study population included 184 frail elderly 
and 83 informal caregivers in the experimental group and 193 frail 
elderly and 76 informal caregivers in the control group.
Measures
Effects
The primary outcome of the intervention was quality of life, which 
was operationalized with health-related quality of life measured with 
the EQ-5D instrument. The EQ-5D has five dimensions: mobility, 
self-care, usual activities, pain/discomfort and anxiety/depression. 
Each dimension has three answering categories: (i) no problems; (ii) 
some problems and (iii) extreme problems. The answer to each of 
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these 5 dimensions leads to a combination of 5 numbers and 243 pos-
sible health states (e.g. health state 21232 means: having some prob-
lems in walking about, having no problems with self-care; having 
some problems with performing usual activities; having extreme pain 
or discomfort; being moderately anxious or depressed). The health 
states unconscious and dead were added, which makes a total of 245 
health states that were valued by the Dutch audience on their desir-
ability. In previous research a general sample of the Dutch audience 
was asked to indicate what period of time in perfect health (11111) 
was equal to 10 years in a specific health state (e.g. 21232) (14). The 
weights obtained in this research were used to calculate the utility 
scores of the frail elderly of our study population. Measurements of 
these utility scores were obtained at baseline, 3 and 12 months and 
were used to calculate quality-adjusted life years (QALYs) for each 
respondent. QALYs combine both quantity and quality of life in one 
single measure; 1 QALY means 1 year in perfect health (14).
Costs
Health care costs, intervention costs and informal care costs were 
calculated by multiplying the volume of care by its corresponding 
cost price.
Health care volumes were collected through questionnaires 
and GP file research (see Table  1). In the questionnaires, the frail 
elderly were asked to indicate the volume of care in assisted living 
facilities and nursing homes, in day care centres and in home care. 
Information on the volume of care in assisted living facilities and 
nursing homes was sought retrospectively after 3 and 12 months. 
The volumes of day care and home care were measured in the 
questionnaire at baseline, 3 and 12  months. These volumes were 
extrapolated with a calculation rule to obtain the volume of care 
over 12 months. The volume at baseline was considered to be the 
volume for the first month, the volume at 3  months was consid-
ered the volume for the second and third months and the volume at 
Figure 1. Flow chart of selection and loss to follow-up of study participants in experimental and control groups
156 Family Practice, 2016, Vol. 33, No. 2
12 months was considered to be the volume for the last 9 months. 
The GP file research led to data regarding the volume of care within 
GP practices, hospitals and paramedical and psychological care. 
Data were not extrapolated, as the files provided the exact date of 
care consumption.
Information on intervention costs was obtained from time regis-
trations of the case managers and notes from the multidisciplinary 
meetings. The exact intervention time and therefore intervention 
costs could be calculated for each individual frail elderly person. The 
education costs of the GPs and case managers were not considered.
Informal care volumes were assessed by questionnaires com-
pleted by informal caregivers of the frail elderly at baseline, 3 and 
12 months. The volume of informal care was measured using the 
Objective Burden of Informal Care Instrument (15) that distin-
guishes time spent on household, personal care and instrumental 
tasks. The same calculation rule was applied as for the health care 
costs assessed in the questionnaire of the frail elderly.
Cost prices were determined using the Dutch guidelines of cost-
ing studies (16). Cost prices were determined in euros for the year 
2011 and were corrected for inflation.
Table 1. Costs of care and data collection
Type of care Data collection Cost price
Questionnaire GP file Time registrations Notes from multidisciplinary 
meeting
€
Health care costs
GP practice
GP Telephone consultation Number 14.51
Consultation Number 29.02
Consultation long Number 58.04
Visit at home Number 44.57
Visit at home long Number 89.13
Practice assistant Telephone consultation Number 5.48
Consultation Number 10.97
Consultation long Number 21.93
Visit at home Number 16.84
Visit at home long Number 33.68
Emergency GP Telephone consultation Number 21.29
Consultation Number 42.58
Visit at home Number 63.88
Hospital Admission—general Days 450.85
Admission—academic Days 595.95
Outpatient clinic—general Number 66.33
Outpatient clinic—academic Number 133.70
Day surgery Number 260.15
Emergency ward Number 156.50
Ambulance Number 271.55
Assisted living 
facility
Temporary stay assisted living 
facility
Days 93.28
Nursing home Temporary stay nursing home Days 246.67
Permanent stay nursing home Days 246.67
Day treatment in nursing home Days 146.66
Home care Home care—household activities Hours 24.87
Home care—personal care Hours 45.60
Home care—nursing care Hours 67.37
Day care centre Day care Days 26.00
Paramedical Physiotherapy Sessions 37.31
Occupational therapy Hours 22.80
Dietitian Hours 27.98
Psychosocial Psychological care Sessions 89.83
Social care Sessions 67.37
Intervention costs
Preparation multidisciplinary 
meeting
Minutes Minutes Variablea
Multidisciplinary meeting Minutes Minutes Variablea
Time spent per patient by case 
manager
Minutes Variablea
Informal care costs
Household activities Hours 24.87
Personal care Hours 45.60
Instrumental tasks Hours 13.00
aThe cost price differs per group health care professionals and is calculated for each group separately.
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Statistical analysis
The costs and the effects were compared by conducting a cost-
effectiveness analysis. First, the background characteristics of the 
experimental and control participants at baseline were compared 
by chi-square tests for the categorical variables and t-tests for the 
continuous variables. Second, the average volume of care and corre-
sponding costs during the 12-month period were compared between 
the experimental and control groups with t-tests (17). The cost-effec-
tiveness of the WICM was determined by calculating the incremental 
cost-effectiveness ratio (ICER). The ICER is calculated by dividing 
the difference between costs of the experimental group and control 
group (incremental costs) by the difference in effects between the 
experimental and control groups (incremental effects). Missing val-
ues were imputed with the fully conditional specification method. 
We determined the reliability of the ICER with the bootstrap 
method, which is a statistical method with repetitive computation 
to determine the confidence interval (CI) of the ICER. By sampling 
from both the distribution of costs and effects concurrently, multiple 
estimates from ICER were obtained (n = 10 000) (10).
Results
The study population consisted of frail elderly patients with an aver-
age age of 82  years and an average score of 6 on the Groningen 
Frailty Indicator (Table  2). Women were over-represented in both 
groups and the majority of the frail elderly lived alone and inde-
pendently. Nearly half of the frail elderly patients had an informal 
caregiver. At baseline, the health-related quality of life was equal in 
both groups. Compared with the control group, the experimental 
group consisted of significantly more women and frail elderly who 
lived in assisted living facilities.
Frail elderly patients most commonly used care from the GP, hos-
pital and home care (Table 3). All experimental participants used GP 
care, as it was the single entry point of care for the intervention. In 
the control group, 4% of the frail elderly did not use any GP care 
over the 1-year period. Three-quarters of the frail elderly visited the 
hospital within 1 year. The highest expenses in both groups were for 
home care and informal care. Only limited differences were observed 
in the health care utilization of the experimental and control group. 
For two types of care, the cost differences were significant. The first 
type was GP care: the costs were significantly higher in the experi-
mental group than in the control group. Furthermore, because the 
intervention costs were 0 in the control group, these costs were sig-
nificantly higher in the experimental group.
The average total costs in the experimental group were 17,089 
euros for each frail elderly person over a 1-year period (Table 4). The 
costs were lower in the control group, with an average of 15,189 
euros for each frail elderly person. The dispersion of costs was high: 
Table 2. Characteristics of the study participants in experimental and control groups at baseline
Experimental group (n = 184) Control group (n = 193) T-statistic or chi square
Groningen Frailty Indicator (0–15) 6.0 (2.0) 5.8 (1.8) −1.3
Age 81.8 (4.7) 82.3 (5.3) 0.8
Sex—women 70% 60% 4.1*
Marital status 0.9
 Married and living together 37% 42%
 Single and widowed 63% 58%
Living situation 6.1*
 Independently 72% 82%
 Assisted living facility 28% 18%
Informal caregiver 45% 39% 1.5
Health-related quality of life (0–1) 0.65 (0.2) 0.67 (0.3) 0.5
*P < 0.05.
Table 3. Costs of care in experimental and control groups 0–12 months
Costs of care Experimental group (n = 184) Control group (n = 193)
% frail elderly using 
care
Mean (€) SD (€) % frail elderly using 
care
Mean (€) SD (€) 95% CI P-value
Health care costs
 GP 100 315 229 96.4 245 191 −133, −27 0.001***
 Emergency GP 25.5 20 50 16.6 12 37 −16, 1 0.104
 Hospital care 76.6 1096 3304 77.7 709 1628 −918, 146 0.154
  Nursing home and assisted 
living
5.4 1244 8389 3.1 820 6987 −1985, 1136 0.593
 Home care 69.0 7084 9573 71.0 6410 10 902 −2756, 1408 0.525
 Day care 5.4 205 1157 8.3 239 1216 −207, 274 0.786
 Paramedical care 42.4 166 361 35.8 136 295 −96, 37 0.380
 Psychosocial care 8.2 10 56 4.1 78 535 −8, 144 0.087
Intervention costs 100 340 188 0 0 0 −368, −313 0.000***
Informal care costs 41.8 6608 15 269 35.2 6469 14 778 −3182, 2904 0.929
SD, standard deviation.
***P < 0.001.
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~21 000 euros in both groups. The total costs did not significantly 
differ between the two groups. The effects were explored in terms of 
health-related quality of life. The average effect in the experimental 
group was 0.00 compared with −0.01 in the control group; this dif-
ference was not significant.
The WICM was not found to be cost-effective after 12 months. 
The intervention does not achieve incremental effects, meaning that 
no additional effects were gained. The incremental costs of the inter-
vention are 1970 euros so the WICM is more expensive than care 
as usual. The costs do not outweigh the effects of the intervention 
after 1 year. The results indicate an ICER of 412 450 euros, implying 
that on average 412 450 should be spent to gain 1 additional QALY 
(1 year in perfect health). The 95% CI of the ICER is −4 131 743 to 
4 210 593. The results of the bootstrap analysis are presented in the 
cost-effectiveness plane (Fig. 2). Very few of the bootstrap results, 
0.21%, appear in the southeast quadrant, meaning that the interven-
tion is more effective and generates lower costs than care as usual.
Conclusions
In this study, we performed an economic evaluation of the WICM, a 
comprehensive integrated care intervention for community-dwelling 
frail elderly including several effective integrated care elements and 
differing considerably from standard care (in the Netherlands). The 
main conclusion is that the WICM is not cost-effective from a soci-
etal perspective over a 12-month period, as the costs do not out-
weigh the effects and the costs per QALY are high.
Because studies of the cost-effectiveness of integrated care show 
mixed results, our study both confirms and contradicts current evi-
dence. With regard to the effects, our study corroborates the limited 
effects of integrated care interventions (8–10). These limited effects 
do not depend on the effect measures, as studies have adopted 
different effect measures, e.g. functional performance, mental health 
(6), frailty state (9) and health-related quality of life (8–11). In our 
cost-effectiveness analysis, we also chose to explore effects on qual-
ity of life because this refers to the subjective appraisal of the frail 
elderly themselves (1). Moreover, we focused on health-related qual-
ity of life because this measure is primarily used for interventions 
that expect effects on patient health (12). However, comparability 
between the studies is limited; it is uncertain what results would have 
been observed if all studies had chosen the same effect measures.
The main difference between our study and earlier research con-
cerns the costs included (i.e. health care costs, intervention costs 
and informal care costs). With regard to the health care costs, the 
types of care that were considered clearly differed among studies. 
Our study included a wide range of costs because the intervention 
focused on physical, psychological and social functioning of the 
elderly. Accordingly, we included costs of both paramedical and 
psychological care, which were not or partially considered in other 
studies from a societal perspective (8,11). Furthermore, intervention 
costs were calculated differently in our study than in other stud-
ies. In these studies, the total intervention costs were calculated 
and divided by the number of intervention participants (8–11). The 
WICM involved specific investments, such as case management and 
time spent on multidisciplinary meetings by all professionals. These 
costs were studied in detail and calculated for each frail elderly per-
son individually. This approach enhanced the validity of our study. 
Finally, informal care costs were considered only in studies adopting 
a societal perspective (8,11). Three of the interventions that were 
considered to be cost-effective (6,7,9) adopted a health care perspec-
tive that did not include the assessment of informal care costs.
This study has several limitations. Our quasi-experimental design 
was chosen to ensure that the frail elderly patients could stay with 
their own GP. As randomization of the frail elderly made this impossi-
ble, a quasi-experimental design was the second best choice. However, 
quasi-experimental designs may risk baseline differences between 
the experimental and control groups. In our study, the experimental 
group consisted of more women and more elderly living in assisted 
living facilities compared with the control group. However, these dif-
ferences did not influence our results, as previous research has shown 
no clear association between sex and quality of life (18) or between 
living in an assisted living facility and quality of life (19). This also 
applies to the costs of care, which were not found to be higher for 
women (20) or for elderly in assisted living (21). Additionally, with 
Table 4. Effects and total costs of care in experimental and control 
groups 0–12 months
Experimental  
group
Control  
group
95% CI P-value
Effects— 
EQ-5D
0.00 (0.19) −0.01 (0.17) −0.04, 0.03 0.80
Total costs 17 089 (21 468) 15 189 (21 709) −6344, 2405 0.38
Figure 2. Cost-effectiveness plane—costs (euros) versus effects (QALY) of WICM versus care as usual
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the quasi-experimental design, we might have selectively included GPs 
in the experimental group who initially already had a more proactive 
attitude toward the delivery of care to frail elderly patients. Because 
a proactive attitude has an effect on elderly’s quality of life (1), the 
choice not to randomize the GPs might have led to a smaller effect on 
the change in quality of life for the experimental group. Although the 
quality of life at baseline did not significantly differ in the two groups, 
we have no information regarding changes in the quality of life prior 
to the beginning of the intervention. The selection of intervention GPs 
could also mean that these GPs are more likely to participate in care 
activities for the frail elderly, leading to higher care costs irrespective 
of the costs associated with the WICM.
The second limitation is related to the calculation of care costs. 
In this study, precise data on the volume of some types of formal and 
informal care were lacking because the elderly patients did not keep 
records of the care they received, a method which is a commonly used in 
cost-effectiveness analyses. Instead, we extrapolated the volume based 
on their health care use at three explicit moments in time (at baseline, 
after 3 and after 12 months). This method could have led to an under-
estimation or overestimation of health care use and informal care and, 
consequently, of the costs of care. Additional analyses also showed that 
the volume of care used at the three moments in time rarely differed.
Third, we did not account for all costs in the cost-effectiveness 
analysis, e.g. costs regarding medication and assistive devices. We 
selected the seemingly most important types of care because it remains 
unknown what specific types of health and social care should be con-
sidered in cost-effectiveness analyses of integrated care interventions 
for the frail elderly. Furthermore, the costs of schooling and training 
were not accounted for because consideration of such costs would 
lead to unrealistically high costs for the experimental group, as the 
return on investment for these costs requires >12 months.
It remains unclear whether integrated care for the frail elderly can 
achieve one of its major aims of being cost-effective and thereby pro-
viding value for money. In current health care systems, this knowledge 
is essential in determining whether integrated care can achieve its high 
expectations. This implies that further research of evaluation studies on 
integrated care should include a cost-effectiveness analysis from a soci-
etal perspective with similar types of care considered. Adopting a soci-
etal perspective, i.e. considering the costs of informal care, is strongly 
recommended (12). This is necessary because informal caregivers have 
become increasingly important in the care of frail elderly patients. 
It is crucial to consider similar costs and effects in cost-effectiveness 
analyses to ensure comparability among studies. More comparable 
cost-effectiveness analyses may help researchers to draw conclusions 
regarding what combinations of integrated care elements are cost-
effective. However, performing such research requires determination 
of the types of care and health issues can be influenced by integrated 
care interventions for the frail elderly and should thus be considered 
relevant costs and effects in future cost-effectiveness analyses.
Second, future research may explore whether other goals of the 
WICM are achieved, such as improvements in the quality of care and 
consumer satisfaction. Because of a possible trade-off between the 
various goals of integrated care, focusing solely on cost-effectiveness 
might impede the implementation of a potentially successful inte-
grated care arrangement for frail elderly patients.
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